The challenges of coronary no‐reflow phenomenon

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Mar 2021 English Publisher:WileyJournal:Catheterization and Cardiovascular Interventions, volume 97, pages 612-613 (issn: 1522-1946, eissn: 1522-726X,

Copyright policy )

Authors: Brian C. Case; Lowell F. Satler;

doi: 10.1002/ccd.29571

pmid: 33721406

The challenges of coronary no‐reflow phenomenon

- Summary
- Subjects
- Metrics

Abstract

Key Points Proof‐of‐concept study demonstrates that intracoronary epinephrine could provide substantial improvement in coronary flow in ST‐elevation myocardial infarction refractory coronary no‐reflow during primary percutaneous coronary intervention. Intracoronary epinephrine is a potential solution to an uncommon but clinically serious phenomenon with limited, if any, therapeutic alternatives. A prospective, large, randomized trial, which is powered for clinical events, would help further validate this management technique.

Related Organizations

Washington Hospital
United States
MedStar Washington Hospital Center
United States

Keywords

Percutaneous Coronary Intervention, Treatment Outcome, Humans, No-Reflow Phenomenon, Coronary Angiography

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	5
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%